Democratic senator defends working with Trump after Booker's 'complicity' accusation
Cortez Masto was asked by the New York Times to respond to Booker's accusations against Democrats that they were "complicit" with President Donald Trump's agenda.
"I don't need lectures from anyone on how to push back and fight this administration. I've been doing it since I got to the Senate, because I won my Senate race in 2016 and Donald Trump won at the same time. I'm also from a swing state; I've still got to get stuff done on behalf of my state," Masto told The New York Times.
"I've been doing it since I got to the Senate, because I won my Senate race in 2016 and Donald Trump won at the same time. I'm also from a swing state; I've still got to get stuff done on behalf of my state," she added.
Booker accused his fellow Democratic senators last week of aligning themselves with Trump because they are in favor of passing new police legislation. He claimed that without amendments, the legislation would allow the president to pick winners and losers in terms of who receives the benefits.
"That is complicity with an authoritarian leader who is trashing our country," Booker said. "It is time for Democrats to have a backbone. It's time for us to fight. It's time for us to draw a line, and when it comes to the safety of my state being denied these grants, that's why I'm standing here."
Booker's objection stemmed from a call from Democrats to pass a package of law enforcement-related bills aimed at boosting resources for police, including resources to help shore up death benefits for police officers lost in the line of duty, resources for greater mental health support for officers, resources to address child exploitation.
The bills, which eventually passed, were discussed and approved in committee before reaching the Senate floor.
Masto thought Trump's legislation would benefit everyone across the country.
"Why would you throw out good legislation that's going to benefit everyone across the country? That doesn't make sense. We still have to have a functioning government. That's part of gaining the trust of Americans again, so they understand there are people that are working on their behalf," Masto said. "But most importantly, we have to win. Winning means we've got to win these swing states, and focus on those swing voters and what matters to them and talk to them and that we're addressing the issues they care about."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Washington Post
32 minutes ago
- Washington Post
Justice Department targets New York attorney general, a Trump foe. Here's what to know
NORFOLK, Va. — President Donald Trump's Justice Department is zeroing in on New York Attorney General Letitia James with a subpoena for records related to the $454 million civil judgement she won against Trump for lying about his wealth, a person familiar with the matter has told The Associated Press.
New York Times
32 minutes ago
- New York Times
Ousted F.D.A. Vaccine Chief Returns to Agency
Dr. Vinay Prasad, who led the Food and Drug Administration's vaccines and gene therapy division before resigning under pressure two weeks ago, is returning to the agency, a Department of Health and Human Services spokesman confirmed Saturday. Dr. Prasad left the F.D.A. in late July after being targeted by the right-wing activist Laura Loomer and others who criticized his decisions regarding certain medications and pointed out critical comments he had made about President Trump before joining the administration. A series of editorials published in the weeks leading up to Dr. Prasad's resignation also appeared to have contributed to the pressure on him. Those editorials found fault with his decisions to deny drug approvals and to demand a pause on a medication linked to several patient deaths. Dr. Prasad's return was an unusual instance of a federal official being allowed to rejoin the administration after being targeted by Ms. Loomer for being insufficiently loyal to the president. She has repeatedly demonstrated her influence over federal personnel decisions. His rehiring also suggests that the health secretary, Robert F. Kennedy Jr., and the F.D.A. commissioner, Dr. Marty Makary, remain influential enough in the Trump administration to employ someone who had previously expressed disdain for Mr. Trump and his followers. 'At the F.D.A.'s request, Dr. Vinay Prasad is resuming leadership of the Center for Biologics Evaluation and Research,' Andrew Nixon, a health department spokesman, said in a statement. In a post on X Saturday, Ms. Loomer called Dr. Prasad's return 'another egregious personnel decision,' describing him as a 'Marxist.' She also pledged to ramp up her campaign against other health officials she deemed 'rabid Trump haters.' Before the resignation, Mr. Kennedy and Dr. Makary had defended Dr. Prasad against the mounting attacks, even as those seeking to have him fired lobbied the White House directly with their concerns, people familiar with the conversations said. Dr. Makary called him an 'impeccable scientist,' and Mr. Kennedy told an associate he wanted Dr. Prasad at the F.D.A. in part because of his approach to vaccines, according to people familiar with the conversation. Dr. Prasad had played a key role in the decision in May to limit the use of the Covid vaccine to people over 65 and to those with medical conditions that put them at high risk for severe illness. Their advocacy fell short, though, and Dr. Prasad issued his resignation on July 29. Dr. Prasad's long-running penchant for sharp criticism of the federal health bureaucracy, often peppered with expletives, led to intense speculation about the reasons for his ouster. It was a surprise to many in medical circles when Dr. Makary said at an event with Mr. Kennedy earlier this week that he was seeking to bring Dr. Prasad back to the F.D.A. Before entering government, Dr. Prasad was an oncologist and epidemiologist at the University of California, San Francisco, where he was active on Substack, YouTube and other social media sites, often excoriating public health officials for their approaches to the pandemic and what he viewed as poor decisions by the F.D.A. After joining the agency, he attracted attention for declining to approve several drugs, including one meant to treat advanced skin cancer and another meant to treat heart conditions for patients with a rare muscle disorder. Dr. Prasad had long called on the F.D.A. to take a stronger stance against drugs with a high price tag and uncertain benefits for patients. He has taken a similar position on vaccines, saying they need more careful examination before authorization and heightened scrutiny after. In the weeks before his ouster, Dr. Prasad also called on the company Sarepta Therapeutics to stop shipping its gene therapy drugs after the deaths of two teenagers and a 51-year-old man were deemed related to the medication. The company initially refused but later conceded. Since then, the company has resumed shipments of the medication for younger patients.
Fox News
32 minutes ago
- Fox News
Israel needs to ‘drive a wedge' between Hamas and civilians in Gaza: Dan Hoffman
Fox News contributor and former CIA station chief Dan Hoffman discusses the current state of the Israel-Hamas conflict and the upcoming Trump-Putin summit on 'Fox News Live.'
